An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis
Clinical trial NCT01803867 · COMPLETED
Trial details
- NCT number
- NCT01803867
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-10-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.